FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109164075> ?p ?o ?g. }

• W2109164075 endingPage "196" @default.
• W2109164075 startingPage "189" @default.
• W2109164075 abstract "A substantial number of individuals with type 2 diabetes mellitus (T2DM) demonstrate a predominance of small dense low-density lipoprotein (sdLDL), which is associated with an increased risk of cardiovascular disease (CVD). In some cases, sdLDL persists after treatment with a statin to reduce levels of LDL. The effect of the addition of a thiazolidinedione, rosiglitazone (RSG) (4 mg/day or 8 mg/day) to statin therapy on LDL phenotype and C reactive protein (CRP) levels was investigated in a 12-week, placebo-controlled study of 72 T2DM patients who were well controlled and on a statin, but who had persistently predominant sdLDL. Addition of RSG 8 mg to statin therapy significantly increased LDL buoyancy (relative flotation +0.014, p=0.003) and LDL particle size (+4.2Å, p=0.001) from baseline and relative to the change with placebo (+0.014 and +3.8Å; p=0.03 and p=0.04, respectively), and was associated with a non-significant decrease in sdLDL. RSG 8 mg moderately, but significantly, increased total cholesterol (by 12.2%, p=0.004), LDL-cholesterol (11.2%, p=0.02) and intermediate-density lipoprotein (IDL)-cholesterol from baseline but did not increase total or LDL apolipoprotein B. RSG 4 mg and 8 mg significantly reduced CRP compared with placebo (-44.9% and-48.0%; p=0.008 and p=0.004, respectively), and significantly reduced insulin resistance and fasting plasma glucose from baseline. Addition of RSG to statin therapy may further reduce cardiovascular risk by improving the LDL phenotype, as well as reducing insulin resistance and CRP levels. However, the increase in IDL may be proatherogenic and must be considered when assessing the benefits of rosiglitazone." @default.
• W2109164075 created "2016-06-24" @default.
• W2109164075 creator A5006401701 @default.
• W2109164075 creator A5009695940 @default.
• W2109164075 creator A5014367124 @default.
• W2109164075 creator A5027867701 @default.
• W2109164075 creator A5032144691 @default.
• W2109164075 creator A5067464347 @default.
• W2109164075 creator A5082757276 @default.
• W2109164075 date "2006-12-01" @default.
• W2109164075 modified "2023-09-29" @default.
• W2109164075 title "Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy" @default.
• W2109164075 cites W1502524639 @default.
• W2109164075 cites W1974128108 @default.
• W2109164075 cites W1977386411 @default.
• W2109164075 cites W1996686380 @default.
• W2109164075 cites W1999551921 @default.
• W2109164075 cites W2008742028 @default.
• W2109164075 cites W2018715171 @default.
• W2109164075 cites W2022805973 @default.
• W2109164075 cites W2027825904 @default.
• W2109164075 cites W2050758709 @default.
• W2109164075 cites W2056594106 @default.
• W2109164075 cites W2063257157 @default.
• W2109164075 cites W2072308694 @default.
• W2109164075 cites W2101333957 @default.
• W2109164075 cites W2102899779 @default.
• W2109164075 cites W2107295258 @default.
• W2109164075 cites W2124620553 @default.
• W2109164075 cites W2132984693 @default.
• W2109164075 cites W2147375465 @default.
• W2109164075 cites W2155315233 @default.
• W2109164075 cites W2156722540 @default.
• W2109164075 cites W2159969745 @default.
• W2109164075 cites W2164346577 @default.
• W2109164075 cites W2170954426 @default.
• W2109164075 cites W2319208205 @default.
• W2109164075 cites W2331274940 @default.
• W2109164075 doi "https://doi.org/10.3132/dvdr.2006.029" @default.
• W2109164075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17160915" @default.
• W2109164075 hasPublicationYear "2006" @default.
• W2109164075 type Work @default.
• W2109164075 sameAs 2109164075 @default.
• W2109164075 citedByCount "22" @default.
• W2109164075 countsByYear W21091640752012 @default.
• W2109164075 countsByYear W21091640752013 @default.
• W2109164075 countsByYear W21091640752014 @default.
• W2109164075 countsByYear W21091640752020 @default.
• W2109164075 countsByYear W21091640752023 @default.
• W2109164075 crossrefType "journal-article" @default.
• W2109164075 hasAuthorship W2109164075A5006401701 @default.
• W2109164075 hasAuthorship W2109164075A5009695940 @default.
• W2109164075 hasAuthorship W2109164075A5014367124 @default.
• W2109164075 hasAuthorship W2109164075A5027867701 @default.
• W2109164075 hasAuthorship W2109164075A5032144691 @default.
• W2109164075 hasAuthorship W2109164075A5067464347 @default.
• W2109164075 hasAuthorship W2109164075A5082757276 @default.
• W2109164075 hasBestOaLocation W21091640751 @default.
• W2109164075 hasConcept C126322002 @default.
• W2109164075 hasConcept C134018914 @default.
• W2109164075 hasConcept C142724271 @default.
• W2109164075 hasConcept C204787440 @default.
• W2109164075 hasConcept C27081682 @default.
• W2109164075 hasConcept C2776839432 @default.
• W2109164075 hasConcept C2776914184 @default.
• W2109164075 hasConcept C2776923340 @default.
• W2109164075 hasConcept C2777180221 @default.
• W2109164075 hasConcept C2778163477 @default.
• W2109164075 hasConcept C2780072125 @default.
• W2109164075 hasConcept C2780152017 @default.
• W2109164075 hasConcept C2781195455 @default.
• W2109164075 hasConcept C555293320 @default.
• W2109164075 hasConcept C62746215 @default.
• W2109164075 hasConcept C71924100 @default.
• W2109164075 hasConceptScore W2109164075C126322002 @default.
• W2109164075 hasConceptScore W2109164075C134018914 @default.
• W2109164075 hasConceptScore W2109164075C142724271 @default.
• W2109164075 hasConceptScore W2109164075C204787440 @default.
• W2109164075 hasConceptScore W2109164075C27081682 @default.
• W2109164075 hasConceptScore W2109164075C2776839432 @default.
• W2109164075 hasConceptScore W2109164075C2776914184 @default.
• W2109164075 hasConceptScore W2109164075C2776923340 @default.
• W2109164075 hasConceptScore W2109164075C2777180221 @default.
• W2109164075 hasConceptScore W2109164075C2778163477 @default.
• W2109164075 hasConceptScore W2109164075C2780072125 @default.
• W2109164075 hasConceptScore W2109164075C2780152017 @default.
• W2109164075 hasConceptScore W2109164075C2781195455 @default.
• W2109164075 hasConceptScore W2109164075C555293320 @default.
• W2109164075 hasConceptScore W2109164075C62746215 @default.
• W2109164075 hasConceptScore W2109164075C71924100 @default.
• W2109164075 hasIssue "3" @default.
• W2109164075 hasLocation W21091640751 @default.
• W2109164075 hasLocation W21091640752 @default.
• W2109164075 hasOpenAccess W2109164075 @default.
• W2109164075 hasPrimaryLocation W21091640751 @default.
• W2109164075 hasRelatedWork W1990007208 @default.
• W2109164075 hasRelatedWork W2009862783 @default.
• W2109164075 hasRelatedWork W2014113220 @default.

• next